|
|
Article: Bioanalytical Systems, Inc. Announces $7.75 Million Sale-Leaseback of Baltimore Facility.
- Article from:
- Business Wire
- Article date:
- July 26, 2004
CopyrightCOPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WEST LAFAYETTE, Ind. -- Bioanalytical Systems, Inc. (Nasdaq:BASI) today announced that it has reached an agreement (in principle) providing for the sale and leaseback of the building that currently houses its clinical research facility in downtown Baltimore, Maryland. BASi will receive $7.75 million in cash from the transaction and will lease 85% of the building for two years at near market rate. Proceeds from the transaction will be used to reduce debt. Closing of the transaction is subject to satisfactory completion of due diligence and execution of a definitive purchase agreement.
Bioanalytical Systems, Inc. is a pharmaceutical development company providing ...
Related newspaper, magazine, and journal articles:
|
|
Article: Bioanalytical Systems, Inc. to Present at Wall ...
Business Wire;
February 4, 2002 ;
670 words
... ... Feb. 4, 2002 Bioanalytical Systems, Inc. (Nasdaq ... 021102.htm. Bioanalytical Systems, Inc. is a ... complete profile of Bioanalytical Systems, Inc. can be ... Securities and Exchange Commission.
|
|